Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of CYP2C19 Gene Polymorphism on Long-term Major Adverse Cardiac and Vascular Events

NCT06855394 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06855394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of CYP2C19 Gene Polymorphism on Long-term Major Adverse Cardiac and Vascular Events
Lead sponsor
University of Florida
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2011
Completion date
December 31, 2026
Enrollment
13,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis of arteries of the extremities, unspecified, atherosclerosis of coronary artery, atherosclerotic vascular disease, coronary arterial disease (cad), heart diseases, stroke, venous thromboembolic disease